Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation [EARLY_Phase 1]
Early Phase 1 trial updating on identification of allergic asthmatics reactive to cat hair allergen; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy [Phase 3]
Phase 3 trial comparing abrocitinib to dupilumab in adults with moderate-to-severe atopic dermatitis on topical therapy has completed with r…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis [Phase 3]
Long-term Phase 3 study assessing the safety and efficacy of baricitinib (LY3009104) for atopic dermatitis. The trial has completed and resu…
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2b trial evaluating ISB 830 for adults with moderate to severe atopic dermatitis has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood [Phase 3]
Phase 3 trial update investigating a moisturizer to prevent symptoms of atopic dermatitis in early childhood.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating modified Qing-Ying Decoction for atopic dermatitis in children; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating REGN3500 in adults with moderate-to-severe atopic dermatitis has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study of Kyowa Kirin's anti-OX40 monoclonal antibody KHK4083 in moderate-to-severe atopic dermatitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis [Phase 1]
A Phase 1 clinical trial evaluating PF-06817024 in healthy subjects, and in patients with chronic rhinosinusitis with nasal polyps and atopi…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032 [Phase 2]
Long-term safety data from a Phase 2 study of BI 655130 in patients with atopic dermatitis; the trial was terminated and results were posted…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers [Phase 4]
Phase 4 clinical study evaluating adherence to methylprednisolone aceponate in different carriers for chronic eczema.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of DS107 for adults with moderate to severe atopic dermatitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. [Phase 3]
Phase 3 trial evaluating lebikizumab with topical corticosteroid in moderate-to-severe atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis [Phase 3]
Phase 3 trial update for Crisaborole in Chinese and Japanese children aged ≥2 with mild to moderate atopic dermatitis completed; results pos…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis [Phase 3]
A Phase III clinical trial update for Benvitimod Cream in mild to moderate atopic dermatitis is reported but status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD) [Phase 2]
Phase 2 trial update of subcutaneously administered CM310 vs placebo in moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis [Phase 2]
A Phase 2 study evaluating the efficacy and safety of oral difelikefalin (CR845) for moderate to severe pruritus in subjects with atopic der…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating FB825 in adults with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis [Phase 2]
Phase 2 trial update evaluating efficacy, pharmacokinetics, and safety of FB825 in adults with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating Upadacitinib in combination with topical corticosteroids for adolescents and adults with moderate-to-severe atopi…
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) [Phase 3]
A Phase 3 trial (Measure Up 2) evaluating Upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis has completed and…
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) [Phase 3]
Phase 3 study measuring upadacitinib in adolescents and adults with moderate to severe atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study [Phase 2]
Phase 2 trial update for Medihoney Derma Cream in children with mild to moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis [Phase 2]
Phase 2 study on tezepelumab for atopic dermatitis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 1, Phase 2]
A clinical trial update for CM326 in moderate-to-severe atopic dermatitis (Phase 1/Phase 2) with status currently unknown.